Showing 11 authorised medicines
Medicine Active substance Licence holder Status
COSOPT 20 mg/ml + 5 mg/ml eye drops, solution PPA0465/296/001
Dorzolamide, Timolol
PCO Manufacturing Ltd. —
COSOPT 20 mg/ml + 5 mg/ml eye drops, solution PPA1463/060/001
Timolol, Dorzolamide
IMED Healthcare Ltd., —
Duotrav (Extravan) 40 micrograms/mL + 5 mg/mL eye drops, solution EU/1/06/338/001-003
Travopost, Timolol, Timolol Maleate
Novartis Europharm Limited —
Fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container PA1107/014/001
Timolol, Latanoprost
Laboratoires Thea Marketed
Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution EU/1/06/340/001-002
Bimatoprost, Timolol
AbbVie Deutschland GmbH & Co. KG —
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container PA0879/003/001
Tafluprost, Timolol
Santen OY Marketed
Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container PPA0465/475/001
Tafluprost, Timolol
PCO Manufacturing Ltd. —
Timolol 0.25% w/v Eye Drops, Solution PA23148/003/001
Timolol
Brown & Burk IR Limited Marketed
Timolol 0.5% w/v Eye Drops, Solution PA23148/003/002
Timolol
Brown & Burk IR Limited Marketed
Xalacom 50 micrograms/ml + 5 mg/ml, eye drops, solution PPA0465/406/001
Latanoprost, Timolol
PCO Manufacturing Ltd. —
Xalacom 50 micrograms/mL + 5 mg/mL, eye drops, solution PA23355/056/001
Latanoprost, Timolol
Viatris Healthcare Limited Marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.